Cradle is an AI Protein & Enzyme Design company founded in 2021 and based in Amsterdam, Netherlands. It has raised $100M in total funding, most recently a Series B in 2024.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Nov 26, 2024 | Series B | $73M | — | IVP |
| Nov 27, 2023 | Series A | $24M | — | Index Ventures |
Cradle's flagship platform is a web-based SaaS that scientists use to design and optimize proteins for traits such as stability, activity, and expression. It pairs generative AI models trained on protein data with each customer's own wet-lab measurements, suggesting new sequence variants and learning from results across iterative design rounds. The tool is built so biologists without machine-learning backgrounds can run AI-guided protein engineering, and serves applications across pharmaceuticals, industrial enzymes, food, and sustainable materials.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗